Amgen To Discuss Details Of Repatha™ (Evolocumab) Biologics License Application For The Treatment Of High Cholesterol

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. EAT

Go back to Amgen To Discuss Details Of Repatha™ (Evolocumab) Biologics License Application For The Treatment Of High Cholesterol
Amgen Inc (NASDAQ: AMGN) Delayed: 437.23 -6.89 (1.55%)
Previous Close $444.12    52 Week High $176.85 
Open $437.03    52 Week Low $133.64 
Day High $441.85    P/E 65.85 
Day Low $435.00    EPS $6.64 
Volume 1,656,089